Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Management of pulmonary embolism after recent intracranial hemorrhage: A case report.

Lee WC, Fang HY.

Medicine (Baltimore). 2018 Apr;97(15):e0479. doi: 10.1097/MD.0000000000010479.

2.
3.

Rivaroxaban for the treatment of venous thromboembolism in patients with nephrotic syndrome and low AT-III: A pilot study.

Zhang L, Zhang H, Zhang J, Tian H, Liang J, Liu Z.

Exp Ther Med. 2018 Jan;15(1):739-744. doi: 10.3892/etm.2017.5471. Epub 2017 Nov 8.

4.

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

Jun M, Lix LM, Durand M, Dahl M, Paterson JM, Dormuth CR, Ernst P, Yao S, Renoux C, Tamim H, Wu C, Mahmud SM, Hemmelgarn BR; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

BMJ. 2017 Oct 17;359:j4323. doi: 10.1136/bmj.j4323.

5.

Evaluation of bleeding in patients receiving direct oral anticoagulants.

Hellenbart EL, Faulkenberg KD, Finks SW.

Vasc Health Risk Manag. 2017 Aug 23;13:325-342. doi: 10.2147/VHRM.S121661. eCollection 2017. Review.

6.

Can patients with femoral neck fracture benefit from preoperative thromboprophylaxis?: A prospective randomized controlled trial.

Li Q, Dai B, Xu J, Yao Y, Song K, Zhang H, Chen D, Jiang Q.

Medicine (Baltimore). 2017 Jul;96(29):e7604. doi: 10.1097/MD.0000000000007604.

7.

Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment.

Turpie AGG, Purdham D, Ciaccia A.

Ther Adv Cardiovasc Dis. 2017 Sep;11(9):243-256. doi: 10.1177/1753944717714921. Epub 2017 Jun 27. Review.

8.

Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.

Yhim HY, Lee J, Lee JY, Lee JO, Bang SM.

PLoS One. 2017 May 24;12(5):e0178214. doi: 10.1371/journal.pone.0178214. eCollection 2017.

9.

Direct Oral Anticoagulants Vs. Enoxaparin for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose-Response Meta-analysis.

Boyd RA, DiCarlo L, Mandema JW.

Clin Transl Sci. 2017 Jul;10(4):260-270. doi: 10.1111/cts.12471. Epub 2017 May 23.

10.

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.

Nakamura M, Yamada N, Ito M.

J Atheroscler Thromb. 2017 Jun 1;24(6):560-565. doi: 10.5551/jat.RV17005. Epub 2017 Apr 7. Review.

11.

Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.

Cheung KS, Leung WK.

World J Gastroenterol. 2017 Mar 21;23(11):1954-1963. doi: 10.3748/wjg.v23.i11.1954. Review.

13.

Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.

Bundhun PK, Soogund MZ, Teeluck AR, Pursun M, Bhurtu A, Huang WQ.

BMC Cardiovasc Disord. 2017 Jan 6;17(1):15. doi: 10.1186/s12872-016-0449-2. Review.

14.
15.

Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis.

Venker BT, Ganti BR, Lin H, Lee ED, Nunley RM, Gage BF.

J Arthroplasty. 2017 Feb;32(2):645-652. doi: 10.1016/j.arth.2016.09.033. Epub 2016 Oct 5. Review.

16.

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.

Secemsky EA, Butala NM, Kartoun U, Mahmood S, Wasfy JH, Kennedy KF, Shaw SY, Yeh RW.

J Am Heart Assoc. 2016 Oct 17;5(10). pii: e004310.

17.

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.

Mantha S, Laube E, Miao Y, Sarasohn DM, Parameswaran R, Stefanik S, Brar G, Samedy P, Wills J, Harnicar S, Soff GA.

J Thromb Thrombolysis. 2017 Feb;43(2):166-171. doi: 10.1007/s11239-016-1429-1.

18.

Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.

Milling TJ Jr, Kaatz S.

Am J Med. 2016 Nov;129(11S):S80-S88. doi: 10.1016/j.amjmed.2016.06.009. Epub 2016 Aug 27. Review.

19.
20.

The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.

Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, Vogtländer K, Turpie AG.

Vasc Health Risk Manag. 2016 May 18;12:209-18. doi: 10.2147/VHRM.S100293. eCollection 2016.

Supplemental Content

Loading ...
Support Center